Last year, in May, the foreign parent of Fresenius Kabi, an Indian oncology drugs company, announced its intention to sell up to 15% promoter stake and reduce its shareholding to 75% via one or more OFS.
first published: Jun 22, 2013 02:50 pm
A collection of the most-viewed Moneycontrol videos.
Nifty Slips Below 26,100 Amid Sluggish Trade, Midcaps Struggle; IT Lends Support | Closing Bell Live
Live: Can Nifty reach its all-time high levels this week? | Opening Bell
This Tenant says Andheri West is better than SOBO | The tenant
Nifty Clocks Second Week Of Gains But Still Awaits New Peak;Midcaps Snap 7-Week Run|Closing Bell
